China should change its official name for COVID-19 to reflect the virus' mutation, and patients with light symptoms should be allowed to quarantine at home, a leading authority on traditional ...

ALNEO included patients with potentially resectable disease and treated them with neoadjuvant alectinib for two cycles, ...

A new coronavirus variant, currently known as the B.1.1.529 variant, has been recently detected in Botswana and South Africa.

Trial demonstrates 49% confirmed ORR in the 30mg onvansertib dose arm versus 30% confirmed ORR in the control arm in ...

New long-term data highlights the effectiveness and safety of ivosidenib with azacitidine for treating IDH1-mutated AML, ...

In the ongoing Phase II CRDF-004 trial, onvansertib plus standard-of-care showed a 49% confirmed ORR and early PFS benefit in ...

"A mutated eye offers a glimpse of a key protein for preventing cancer." ScienceDaily. ScienceDaily, 9 August 2022. <www.sciencedaily.com / releases / 2022 / 08 / 220809101810.htm>.